Annual ROA
-107.75%
-35.41%-48.95%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual return on assets is -107.75%, with the most recent change of -35.41% (-48.95%) on December 31, 2023.
- During the last 3 years, AVDL annual ROA has fallen by -110.79% (-3644.41%).
- AVDL annual ROA is now -493.54% below its all-time high of 27.38%, reached on December 31, 2017.
Performance
AVDL ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-42.62%
+16.78%+28.25%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly return on assets is -42.62%, with the most recent change of +16.78% (+28.25%) on September 30, 2024.
- Over the past year, AVDL quarterly ROA has increased by +52.52% (+55.20%).
- AVDL quarterly ROA is now -235.22% below its all-time high of 31.52%, reached on September 30, 2017.
Performance
AVDL Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
AVDL ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -49.0% | +55.2% |
3 y3 years | -3644.4% | +53.5% |
5 y5 years | -150.8% | +53.5% |
AVDL ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -289.4% | at low | -54.1% | +55.8% |
5 y | 5-year | -3644.4% | at low | -573.6% | +55.8% |
alltime | all time | -493.5% | at low | -235.2% | +62.2% |
Avadel Pharmaceuticals ROA History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -42.62%(-28.2%) |
Jun 2024 | - | -59.40%(-33.5%) |
Mar 2024 | - | -89.37%(-6.1%) |
Dec 2023 | -107.75%(+48.9%) | -95.14%(-1.4%) |
Sep 2023 | - | -96.52%(+5.2%) |
Jun 2023 | - | -91.76%(+3.3%) |
Mar 2023 | - | -88.82%(+16.9%) |
Dec 2022 | -72.34%(+161.4%) | -75.96%(+19.0%) |
Sep 2022 | - | -63.85%(+11.6%) |
Jun 2022 | - | -57.19%(+65.7%) |
Mar 2022 | - | -34.52%(+24.8%) |
Dec 2021 | -27.67%(-1010.2%) | -27.65%(+23.3%) |
Sep 2021 | - | -22.42%(+24.6%) |
Jun 2021 | - | -17.99%(+862.0%) |
Mar 2021 | - | -1.87%(-171.4%) |
Dec 2020 | 3.04%(-115.6%) | 2.62%(-60.1%) |
Sep 2020 | - | 6.57%(-27.0%) |
Jun 2020 | - | 9.00%(-173.0%) |
Mar 2020 | - | -12.33%(-37.9%) |
Dec 2019 | -19.45%(-54.7%) | -19.85%(-59.8%) |
Sep 2019 | - | -49.42%(+6.8%) |
Jun 2019 | - | -46.28%(+23.3%) |
Mar 2019 | - | -37.53%(+7.1%) |
Dec 2018 | -42.97%(-256.9%) | -35.05%(+155.5%) |
Sep 2018 | - | -13.72%(+1659.0%) |
Jun 2018 | - | -0.78%(-107.2%) |
Mar 2018 | - | 10.76%(-59.2%) |
Dec 2017 | 27.38%(-252.8%) | 26.38%(-16.3%) |
Sep 2017 | - | 31.52%(+100.9%) |
Jun 2017 | - | 15.69%(-524.1%) |
Mar 2017 | - | -3.70%(-78.2%) |
Dec 2016 | -17.92%(-183.5%) | -17.01%(-249.6%) |
Sep 2016 | - | 11.37%(+32.7%) |
Jun 2016 | - | 8.57%(-19.8%) |
Mar 2016 | - | 10.69%(-49.4%) |
Dec 2015 | 21.47%(-136.5%) | 21.11%(-161.6%) |
Sep 2015 | - | -34.29%(+41.5%) |
Jun 2015 | - | -24.24%(-9.5%) |
Mar 2015 | - | -26.77%(-49.2%) |
Dec 2014 | -58.85%(+60.1%) | -52.68%(+50.9%) |
Sep 2014 | - | -34.92%(+1.0%) |
Jun 2014 | - | -34.59%(-25.3%) |
Mar 2014 | - | -46.32%(+27.6%) |
Dec 2013 | -36.76%(+962.4%) | -36.30%(+10.7%) |
Sep 2013 | - | -32.80%(+3.5%) |
Jun 2013 | - | -31.70%(+235.8%) |
Mar 2013 | - | -9.44%(+234.8%) |
Dec 2012 | -3.46%(-71.6%) | -2.82%(-79.8%) |
Sep 2012 | - | -13.96%(+117.1%) |
Jun 2012 | - | -6.43%(+42.6%) |
Mar 2012 | - | -4.51%(-62.7%) |
Dec 2011 | -12.18%(+14.6%) | -12.09%(+123.9%) |
Sep 2011 | - | -5.40%(-56.0%) |
Jun 2011 | - | -12.27%(-7.2%) |
Mar 2011 | - | -13.22%(+17.3%) |
Dec 2010 | -10.63% | -11.27%(-45.3%) |
Sep 2010 | - | -20.59%(+3.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2010 | - | -19.89%(+9.3%) |
Mar 2010 | - | -18.19%(+49.0%) |
Dec 2009 | -12.29%(-1.8%) | -12.21%(+33.4%) |
Sep 2009 | - | -9.15%(+15.4%) |
Jun 2009 | - | -7.93%(+5.3%) |
Mar 2009 | - | -7.53%(-39.1%) |
Dec 2008 | -12.51%(-64.1%) | -12.37%(-19.0%) |
Sep 2008 | - | -15.28%(-28.4%) |
Jun 2008 | - | -21.33%(-30.8%) |
Mar 2008 | - | -30.81%(-12.6%) |
Dec 2007 | -34.89%(+18.6%) | -35.26%(+2.1%) |
Sep 2007 | - | -34.55%(-1.1%) |
Jun 2007 | - | -34.94%(+14.0%) |
Mar 2007 | - | -30.65%(+1.1%) |
Dec 2006 | -29.43%(+45.1%) | -30.32%(+0.6%) |
Sep 2006 | - | -30.15%(+0.6%) |
Jun 2006 | - | -29.98%(+5.9%) |
Mar 2006 | - | -28.32%(+42.0%) |
Dec 2005 | -20.28%(-321.4%) | -19.94%(+110.6%) |
Sep 2005 | - | -9.47%(-976.9%) |
Jun 2005 | - | 1.08%(-83.6%) |
Mar 2005 | - | 6.57%(-33.8%) |
Dec 2004 | 9.16%(-275.5%) | 9.92%(+144.3%) |
Sep 2004 | - | 4.06%(+3283.3%) |
Jun 2004 | - | 0.12%(-79.7%) |
Mar 2004 | - | 0.59%(-104.9%) |
Dec 2003 | -5.22%(-135.8%) | -12.07%(-43.0%) |
Sep 2003 | - | -21.16%(+281.9%) |
Jun 2003 | - | -5.54%(-1.2%) |
Mar 2003 | - | -5.61%(-471.5%) |
Dec 2002 | 14.58%(-197.7%) | 1.51%(-46.8%) |
Sep 2002 | - | 2.84%(-120.8%) |
Jun 2002 | - | -13.64%(+13.3%) |
Mar 2002 | - | -12.04%(-24.0%) |
Dec 2001 | -14.93%(-72.2%) | -15.84%(-534.0%) |
Sep 2001 | - | 3.65%(+81.6%) |
Jun 2001 | - | 2.01%(-47.5%) |
Mar 2001 | - | 3.83%(-116.2%) |
Dec 2000 | -53.63%(+61.2%) | -23.57%(-42.8%) |
Sep 2000 | - | -41.23%(-24.2%) |
Jun 2000 | - | -54.41%(-20.1%) |
Mar 2000 | - | -68.13%(+51.3%) |
Dec 1999 | -33.27%(-0.3%) | -45.02%(+8.4%) |
Sep 1999 | - | -41.53%(+7.8%) |
Jun 1999 | - | -38.51%(+17.3%) |
Mar 1999 | - | -32.83%(-7.9%) |
Dec 1998 | -33.37%(+26.1%) | -35.66%(+18.1%) |
Sep 1998 | - | -30.20%(-10.3%) |
Jun 1998 | - | -33.66%(-8.1%) |
Mar 1998 | - | -36.63%(+17.6%) |
Dec 1997 | -26.46%(+14.6%) | -31.16%(+10.9%) |
Sep 1997 | - | -28.09%(+21.7%) |
Jun 1997 | - | -23.08%(-2.8%) |
Mar 1997 | - | -23.75%(-40.4%) |
Dec 1996 | -23.08% | -39.88%(-64.6%) |
Sep 1996 | - | -112.77%(+35.9%) |
Jun 1996 | - | -82.98%(+160.0%) |
Mar 1996 | - | -31.91% |
FAQ
- What is Avadel Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual ROA year-on-year change?
- What is Avadel Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly ROA year-on-year change?
What is Avadel Pharmaceuticals annual return on assets?
The current annual ROA of AVDL is -107.75%
What is the all time high annual ROA for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual return on assets is 27.38%
What is Avadel Pharmaceuticals annual ROA year-on-year change?
Over the past year, AVDL annual return on assets has changed by -35.41% (-48.95%)
What is Avadel Pharmaceuticals quarterly return on assets?
The current quarterly ROA of AVDL is -42.62%
What is the all time high quarterly ROA for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly return on assets is 31.52%
What is Avadel Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, AVDL quarterly return on assets has changed by +52.52% (+55.20%)